Ofev 150 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FJR56
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,591
Award facts
- Contract value 100% obligated
- $8,590.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency on August 27, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed price delivery order with a completion date of September 18, 2025, and represents a non-set-aside competitive award. The contract will be fulfilled at the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Through this contract structure, the company provides critical medical procurement support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Ofev, a specialty pharmaceutical used in the treatment of pulmonary fibrosis, reflects AmerisourceBergen's role as a key vendor in the federal medical supply chain serving defense and military healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FJR56?
SPE2DB25FJR56 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FJR56 worth?
The government has obligated $8,591 on SPE2DB25FJR56.
Is contract SPE2DB25FJR56 an order under another contract?
Yes. SPE2DB25FJR56 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJR56 competed?
The extent of competition for SPE2DB25FJR56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award